Shagun Singh
Stock Analyst at RBC Capital
(3.22)
# 989
Out of 5,182 analysts
255
Total ratings
48.83%
Success rate
0.75%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Outperform | $105 → $100 | $58.45 | +71.09% | 21 | Apr 23, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $135 → $130 | $93.86 | +38.50% | 19 | Apr 17, 2026 | |
| JNJ Johnson & Johnson | Reiterates: Outperform | $255 | $227.79 | +11.95% | 25 | Mar 30, 2026 | |
| TFX Teleflex | Maintains: Sector Perform | $115 → $125 | $135.52 | -7.76% | 24 | Feb 27, 2026 | |
| INSP Inspire Medical Systems | Maintains: Sector Perform | $90 → $68 | $55.11 | +23.39% | 10 | Feb 12, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $210 → $172 | $149.52 | +15.03% | 5 | Feb 10, 2026 | |
| PEN Penumbra | Downgrades: Sector Perform | $355 → $374 | $325.99 | +14.73% | 16 | Jan 20, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $625 → $650 | $466.64 | +39.29% | 18 | Dec 17, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $92 → $100 | $90.74 | +10.20% | 9 | Dec 17, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $95 → $100 | $82.28 | +21.54% | 24 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $370 → $380 | $182.87 | +107.80% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $118 | $81.90 | +44.08% | 22 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $22 → $17 | $4.32 | +293.52% | 14 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $101 | $82.80 | +21.98% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $85 | $59.32 | +43.29% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $18.63 | +34.19% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $321.43 | +35.33% | 19 | Jan 29, 2025 |
Boston Scientific
Apr 23, 2026
Maintains: Outperform
Price Target: $105 → $100
Current: $58.45
Upside: +71.09%
Abbott Laboratories
Apr 17, 2026
Maintains: Outperform
Price Target: $135 → $130
Current: $93.86
Upside: +38.50%
Johnson & Johnson
Mar 30, 2026
Reiterates: Outperform
Price Target: $255
Current: $227.79
Upside: +11.95%
Teleflex
Feb 27, 2026
Maintains: Sector Perform
Price Target: $115 → $125
Current: $135.52
Upside: -7.76%
Inspire Medical Systems
Feb 12, 2026
Maintains: Sector Perform
Price Target: $90 → $68
Current: $55.11
Upside: +23.39%
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Sector Perform
Price Target: $210 → $172
Current: $149.52
Upside: +15.03%
Penumbra
Jan 20, 2026
Downgrades: Sector Perform
Price Target: $355 → $374
Current: $325.99
Upside: +14.73%
Intuitive Surgical
Dec 17, 2025
Maintains: Outperform
Price Target: $625 → $650
Current: $466.64
Upside: +39.29%
Globus Medical
Dec 17, 2025
Maintains: Outperform
Price Target: $92 → $100
Current: $90.74
Upside: +10.20%
Edwards Lifesciences
Dec 5, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $82.28
Upside: +21.54%
Nov 21, 2025
Maintains: Outperform
Price Target: $370 → $380
Current: $182.87
Upside: +107.80%
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $81.90
Upside: +44.08%
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $4.32
Upside: +293.52%
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $82.80
Upside: +21.98%
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $59.32
Upside: +43.29%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $18.63
Upside: +34.19%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $321.43
Upside: +35.33%